Is This Methadone’s Moment?
|
Medscape, By Megan Brooks
Flemming Awards celebrate dedication, public service in government
|
The Hill, By Lauren Irwin
Agency alert: FDA, NIH push for innovation in smoking cessation therapies
|
The Washington Post, By Rachel Roubein and McKenzie Beard
Why Does Mental Illness Raise the Risk of Severe Covid?
|
The New York Times, By Dani Blum
Ozempic shows promise for alcohol and drug addiction, study finds
|
NPR, By Maria Godoy
The Breakthrough Drug to Conquer Addiction: Ozempic?
|
The New York Times, By Maia Szalavitz
Is Weed Bad For You? Marijuana's Health Impacts Still Aren't Known
|
Bloomberg, By Lisa Jarvis
Double-duty neurons in primary olfactory cortex pick up on more than just scent
|
The Transmitter, By Angie Voyles Askham
Higher buprenorphine doses for opioid use disorder may lower risk for ED, inpatient visits
|
Healio, By Cassandra Jenkins
As America’s Marijuana Use Grows, So Do the Harms
|
New York Times, By Megan Twohey, Danielle Ivory, and Carson Kessler
‘Unprecedented’ decline in US drug overdose deaths gives experts hope
|
The Guardian, By Melody Schreiber
Higher Daily Buprenorphine Doses Help Manage OUD: AMA Recommends Policy Change
|
Medscape, By Marcia Frellick
When abortion politics complicates mothers’ addiction recovery
|
The Washington Post, By Danielle Paquette and Sabrina Malhi
Upping Dose of Anti-Opioid Drug Might Work Better to Curb Addiction
|
HealthDay, By Carole Tanzer Miller
Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid overdoses, study says
|
CNBC, By Annika Kim Constantino
44% of jails have medication to treat opioid withdrawal which can be fatal: study finds.
|
Columbus Dispatch, By Erin Glynn
Ozempic May Decrease Opioid Overdose Risk, Study Suggests: What To Know
|
Forbes, By Arianna Johnson
Fewer than half of US jails provide medications for opioid use disorder
|
The Hill, By Alejandra O’Connell-Domenech
Millions of Americans want to quit smoking. Critics say drugmakers and the FDA are failing them
|
STAT, By Nicholas Florko